Market revenue in 2023 | USD 9.0 million |
Market revenue in 2030 | USD 24.7 million |
Growth rate | 15.6% (CAGR from 2023 to 2030) |
Largest segment | Gmp grade |
Fastest growing segment | GMP Grade |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | R&D Grade, GMP Grade |
Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 85.56% in 2023. Horizon Databook has segmented the Saudi Arabia plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia plasmid DNA manufacturing market can primarily be attributed to various initiatives being undertaken by the government to expand the R&D capabilities in the country. For instance, organizations such as the King Abdullah University of Science and Technology (KAUST) facilitate biotechnology R&D activities in Saudi Arabia.
Furthermore, increasing private and public partnerships for expanding biopharmaceutical industry in the country are anticipated to boost the demand for plasmid DNA manufacturing. For instance, in October 2019, Saudi Arabian Investment Authority (SAGIA) signed an MOU with Korea’s GL Rapha Co. to manufacture biologics worth USD 320 million in the country.
Such initiatives are likely to drive the gene and cell therapy, as well as the vaccine manufacturing industry, in the kingdom and fuel growth of plasmid DNA applications. In addition, biomedical research in Saudi Arabia is gaining attention over the past few years.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account